Clinical Trials in Belgium

• A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzhe… Ended
  2022-501644-15-01 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance T… Ended
  2022-501346-30-00 Phase III Newly Diagnosed Multiple Myeloma with Suboptimal Response Af… Celgene Corp.
• A Study to Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination with Polatuzumab Vedotin Plus Rituximab, Cyclophospha… Ended
  2023-504028-24-00 Phase III Large B-Cell Lymphoma F. Hoffmann-La Roche AG
• Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With HR+/HER2− Metastatic Breast Cancer Who Have Received … Ended
  2022-502593-17-00 Phase III Locally advanced or metastatic hormone receptor (HR)-positiv… Gilead Sciences Inc.
• A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Versus Alpelisib Plus Fulvestrant in Patients with Hormone Recepto… Ended
  2022-502322-41-00 Phase III Metastatic breast cancer F. Hoffmann-La Roche AG
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended
  2022-502779-40-00 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG
• A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neu… Ended
  2022-502728-30-00 Phase I (Other) Small Cell Lung Carcinoma expressing DLL3 Boehringer Ingelheim International GmbH
• LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended
  2022-501419-15-00 Phase III Atrial Fibrillation Janssen - Cilag International
• A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF QRL-20… Ended
  2022-500758-41-00 Phase I Amyotrophic lateral sclerosis Quralis Corp.
• A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended
  2022-501176-26-00 Phase III Acute Ischemic Stroke and High-Risk Transient Ischemic Attac… Janssen - Cilag International
• A Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis Ended
  2024-510627-20-00 Phase III Non-alcoholic Steatohepatitis (NASH) Cirrhosis Madrigal Pharmaceuticals Inc.
• A study of LOXO-783 in Patients with PIK3CA H1047R-Mutant Advanced Breast Cancer and Other Solid Tumors. Ended
  2023-509568-81-00 Phase I Advanced Breast Cancer and Other Solid Tumors Eli Lilly & Co.
• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended
  2022-501024-20-00 Phase III ER+/HER2- Early Breast Cancer Astrazeneca AB
• Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term) Ended
  2024-512580-31-00 Phase III Kidney Transplant Rejection Sangamo Therapeutics Inc.
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB115. Ended
  2023-505643-39-00 Phase I Spinal muscular atrophy Biogen Idec Research Limited
• HOVON 164 HL: Tislelizumab plus Gemcitabine and Cisplatin for Relapsed or Refractory Hodgkin Lymphoma followed by Tislelizumab Consolidation… Ended
  2022-502225-17-00 Phase II Hodgkin lymphoma Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
• A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended
  2022-501576-25-00 Phase III Melanoma Regeneron Pharmaceuticals Inc.
• A long-term follow-up trial of patients previously treated with imlifidase prior to kidney transplantation and a non-comparative transplante… Ended
  2022-502727-21-00 Phase III Highly sensitised patients who have undergone kidney transpl… Hansa Biopharma AB
• STEP Young: A research study on how well semaglutide helps children and teenagers with excess body weight lose weight Ended
  2022-502922-41-00 Phase III Obesity and overweight Novo Nordisk A/S
• Evaluation of Long-Term Safety and Efficacy of Apitegromab in Patients with Spinal Muscular Atrophy (a genetic condition that causes muscle … Ended
  2024-511654-42-00 Phase III Spinal Muscular Atrophy (SMA) Scholar Rock Inc.
• A Study to Examine the Efficacy and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder Ended
  2023-506269-78-00 Phase III CDKL5 Deficiency disorder Zogenix International Limited
• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Ended
  2022-502415-11-00 Phase III Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Ionis Pharmaceuticals Inc.
• A Study of EOS301984 in Adult Participants with Advanced Solid Tumors Ended
  2023-503844-14-00 Phase I Advanced Solid Tumors iTeos Belgium
• A study to test trimodulin in adult hospitalized patients with severe pneumonia Ended
  2022-501352-28-00 Phase III Severe community-acquired pneumonia (sCAP) Biotest GmbH & Co. KGaA

Showing 1,273–1,296 of 2,373 trials